このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Goodness Growth Holdings 過去の業績

過去基準チェック /06

Goodness Growth Holdingsの収益は年間平均-1.3%の割合で減少していますが、 Pharmaceuticals業界の収益は年間増加しています。収益は年間51% 25%割合で増加しています。

主要情報

-1.3%

収益成長率

28.9%

EPS成長率

Pharmaceuticals 業界の成長	23.1%
収益成長率	25.0%
株主資本利益率	n/a
ネット・マージン	-25.6%
前回の決算情報	31 Mar 2024

Recent updates

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Jun 01

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Apr 06

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Feb 01

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Jan 25

Vireo Health International's (CSE:VREO) Shareholders Are Down 55% On Their Shares

Sep 04

収支内訳

Goodness Growth Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

CNSX:GDNS 収益、費用、利益 ( )USD Millions
日付	収益	収益	G+A経費
31 Mar 24	93	-24	31
31 Dec 23	88	-26	32
30 Sep 23	83	-34	33
30 Jun 23	77	-37	36
31 Mar 23	78	-36	35
31 Dec 22	75	-42	37
30 Sep 22	69	-43	39
30 Jun 22	64	-41	39
31 Mar 22	57	-41	39
31 Dec 21	54	-34	39
30 Sep 21	53	-22	36
30 Jun 21	52	-13	34
31 Mar 21	50	-22	40
31 Dec 20	49	-23	39
30 Sep 20	48	-63	44
30 Jun 20	42	-78	45
31 Mar 20	36	-62	35
31 Dec 19	30	-57	28
30 Sep 19	25	-17	20
30 Jun 19	22	-4	15
31 Mar 19	21	-4	12
31 Dec 18	18	-3	12
30 Sep 18	16	-2	9
31 Dec 17	11	0	6
31 Dec 16	4	6	4

質の高い収益: GDNSは現在利益が出ていません。

利益率の向上: GDNSは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: GDNSは利益が出ておらず、過去 5 年間で損失は年間1.3%の割合で増加しています。

成長の加速: GDNSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: GDNSは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 39.8% ) と比較することは困難です。

株主資本利益率

高いROE: GDNSの負債は資産を上回っているため、自己資本利益率を計算することは困難です。

Goodness Growth Holdings 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

First quarter 2024 earnings released: US$0.047 loss per share (vs US$0.066 loss in 1Q 2023)

Goodness Growth Holdings, Inc. to Report Q1, 2024 Results on May 07, 2024

Goodness Growth Holdings, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings released: US$0.19 loss per share (vs US$0.33 loss in FY 2022)

Goodness Growth Holdings, Inc. to Report Q4, 2023 Results on Mar 28, 2024

Third quarter 2023 earnings released: US$0.037 loss per share (vs US$0.066 loss in 3Q 2022)

Recent updates

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Goodness Growth Holdings, Inc. announced that it expects to receive $0.7 million in funding

First quarter 2024 earnings released: US$0.047 loss per share (vs US$0.066 loss in 1Q 2023)

Goodness Growth Holdings, Inc. Appoints Josh Rosen as Chief Executive Officer

Goodness Growth Holdings, Inc. to Report Q1, 2024 Results on May 07, 2024

Goodness Growth Holdings, Inc., Annual General Meeting, Jun 21, 2024

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Goodness Growth Holdings, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings released: US$0.19 loss per share (vs US$0.33 loss in FY 2022)

Goodness Growth Holdings, Inc. to Report Q4, 2023 Results on Mar 28, 2024

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Goodness Growth Holdings, Inc. Announces Departure of Michael Schroeder as General Counsel & Chief Compliance Officer Effective December 15, 2023

Third quarter 2023 earnings released: US$0.037 loss per share (vs US$0.066 loss in 3Q 2022)

Goodness Growth Holdings, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Goodness Growth Holdings, Inc. Announces CFO Changes

New major risk - Financial position

Second quarter 2023 earnings released: US$0.084 loss per share (vs US$0.048 loss in 2Q 2022)

Goodness Growth Holdings, Inc. to Report Q2, 2023 Results on Aug 14, 2023

New minor risk - Shareholder dilution

First quarter 2023 earnings released: US$0.066 loss per share (vs US$0.11 loss in 1Q 2022)

Goodness Growth Holdings, Inc. to Report Q1, 2023 Results on May 15, 2023

Goodness Growth Holdings, Inc. Announces Management Changes

Price target decreased to CA$0.85

Goodness Growth Holdings, Inc. Announces Departure of Christian Gonzalez-Ocasio as Chief Operating Officer

Goodness Growth Holdings, Inc Appoints Josh Rosen to the Role of Interim President

Goodness Growth Holdings, Inc. to Report Q3, 2022 Results on Nov 14, 2022

Goodness Growth Holdings, Inc., Annual General Meeting, Nov 18, 2022

Goodness Growth Holdings, Inc. Announces Launch of Boundary Waters Pre-Rolls in Minnesota

Second quarter 2022 earnings released: US$0.048 loss per share (vs US$0.044 loss in 2Q 2021)

Goodness Growth Holdings, Inc. Announces Unaudited and Condensed Impairment Results for the Quarter Ended June 30, 2022

Goodness Growth Holdings, Inc. Launches Cannabis-Infused Gummies in Minnesota

Goodness Growth Holdings Launches Hicolor™ Cannabis Chews in New York

First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.059 loss in 1Q 2021)

Goodness Growth Holdings, Inc. Reports Consolidated Impairment of Long-Lived Assets for the Three Months Ended March 31, 2022

Price target increased to CA$4.00

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Price target increased to CA$4.00

Verano Holdings Corp. (CNSX:VRNO) entered into a definitive arrangement to acquire Goodness Growth Holdings, Inc. (CNSX:GDNS) for approximately $300 million.

Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt

Goodness Growth Holdings Launches New Line of Cannabis Edibles

Third quarter 2021 earnings released: US$0.078 loss per share (vs US$0.004 loss in 3Q 2020)

Price target decreased to CA$4.00

Goodness Growth Holdings, Inc. Retail Brand Green Goods® to Offer Medical Cannabis Program Information & Discounts At the Minnesota State Fair

Second quarter 2021 earnings released: US$0.044 loss per share (vs US$0.16 loss in 2Q 2020)

Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?

Goodness Growth Holdings Subsidiary Resurgent Biosciences Announces Planned Expansion into Psychedelics Research and Ip Development

Vireo Health International, Inc. Provides Revenue Guidance for the Fiscal Year 2022

First quarter 2021 earnings released: US$0.062 loss per share (vs US$0.076 loss in 1Q 2020)

Vireo Health Expands Ground Cannabis Flower in New York, Offers Largest Selection of Ground Flower At Any New York Dispensary

Insider recently sold CA$4.6m worth of stock

Full year 2020 earnings released: US$0.23 loss per share (vs US$0.67 loss in FY 2019)

Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?

Vireo Health International, Inc. to Report Q4, 2020 Results on Mar 25, 2021

New 90-day high: CA$3.77

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Vireo Health International Inc. Appoints Victor E. Mancebo to its Board of Directors

Price target raised to CA$2.33

New 90-day high: CA$3.09

Vireo Health International, Inc. Launches Amplifi™, the First Terpene-Enhanced Brand of Dry Cannabis Flower

Vireo Health International, Inc. (CNSX:VREO) completed the acquisition of medical and adult-use cannabis cultivation and processing businesses in Nevada.

New 90-day high: CA$1.75

Insider recently sold CA$708k worth of stock

Insider recently sold CA$946k worth of stock

New 90-day high: CA$1.73

Revenue beats expectations

Vireo Health International, Inc. Announces Executive Promotions

Jushi Holdings Inc. (OTCPK:JUSH.F) acquired Pennsylvania Dispensary Solutions, LLC from Vireo Health International, Inc. (CNSX:VREO) for $5 million.

Vireo Health International, Inc. to Report Q3, 2020 Results on Nov 25, 2020

Insider recently sold CA$338k worth of stock

過去基準チェック /06